GBCAs for enhanced MRI of brain tumours
By Bracco Imaging
Miles Kirchin from the division of global medical and regulatory affairs at Bracco Imaging reports the results of a study into the relative efficacy of non-ionic macrocyclic gadolinium-based contrast agents in brain tumour MRI.